‘Critical Step’ For Petros Toward ED Switch Proposal With OTC Label Comprehension Study
Petros Pharmaceuticals anticipates Drug Facts label technology it’s developing for potential switch of its Stendra ED drug also could be used for other OTC switch proposals. • Source: Petros Pharmaceuticals
